Minerva Neurosciences Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -1,456.1% | – | – | – | – | – | – | – | |
| – | -49.0% | -4.3% | -32.9% | +57.4% | +824.6% | +9.1% | -42.2% | -91.6% | +263.9% | -27.5% | +24,120.0% | |
| – | -87.7% | +62.2% | +40.9% | +62.6% | +12.1% | +5.8% | -46.2% | -21.3% | -52.1% | -32.7% | +100,039.3% | |
| – | -86.4% | +45.8% | -221.6% | – | +216.8% | -62.6% | +157.0% | -53.8% | – | – | – | |
| – | -103.2% | – | +2,850.0% | -99.7% | +2,995.4% | -1,426.4% | – | -1,665.7% | – | -106.5% | – | |
| – | +14.9% | +0.0% | +0.0% | -100.0% | – | +544,100.0% | +0.0% | +0.0% | -100.0% | -100.0% | – | |
| – | -1,785.9% | – | -701.6% | – | -79.7% | +74.1% | -100.1% | +0.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -40.2% | -33.4% | -100.0% | – | -20.0% | +2,421.5% | – | – | – | – | – | |
| – | +0.0% | -115.7% | +214.5% | -19.0% | – | – | – | – | – | – | – | |
| – | -25.7% | +99.7% | -38.4% | -107.1% | – | +2,421.5% | +353.2% | -100.0% | – | -100.0% | – | |
| – | -125.5% | – | -182.9% | – | -219.1% | – | +797.4% | -169.7% | – | -505.7% | – | |
| – | – | – | – | -1,479.5% | – | – | – | – | – | – | – |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.